Agreement, Initial Term

No definition available.

Name:	bhvn_AgreementInitialTerm
Namespace Prefix:	bhvn_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Counterparty, Period of Time For Development Activities Prior to Termination

+ References

No definition available.

+ Details

Name:	bhvn_CounterpartyPeriodOfTimeForDevelopmentActivitiesPriorToTermination
Namespace Prefix:	bhvn_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Counterparty, Period of Time to Terminate Agreement After Research Term

+ References

No definition available.

+ Details

Name:	bhvn_CounterpartyPeriodOfTimeToTerminateAgreementAfterResearchTerm
Namespace Prefix:	bhvn_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Earned Royalty Payment Per Agreement, Percentage

+ References

No definition available.

+ Details

Name:	bhvn_EarnedRoyaltyPaymentPerAgreementPercentage
Namespace Prefix:	bhvn_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

Milestone Payment Eligible Per Agreement Upon Specified Performance And Regulatory Milestone Achievements

+ References

No definition available.

+ Details

Name:	bhvn_MilestonePaymentEligiblePerAgreementUponSpecifiedPerformanceAndRegulatoryMilestoneAchievements
Namespace Prefix:	bhvn_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Period Of Time To Terminate Agreement, During Research Term

+ References

No definition available.

+ Details

Name:	bhvn_PeriodOfTimeToTerminateAgreementDuringResearchTerm
Namespace Prefix:	bhvn_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Period Of Time To Terminate Agreement, Following Research Term

+ References

No definition available.

+ Details

Name:	bhvn_PeriodOfTimeToTerminateAgreementFollowingResearchTerm
Namespace Prefix:	bhvn_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 13
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585

+ Details

Name:	us-gaap_PaymentsToAcquireIntangibleAssets
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 985
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 730
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373

+ Details

Name:	us-gaap_ResearchAndDevelopmentExpense
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Number of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination.

+ References

No definition available.

+ Details

Name:	us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Value of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination.

+ References

No definition available.

+ Details

Name:	us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Details

Name:	srt_CounterpartyNameAxis=bhvn_SoseiHeptaresMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_RangeAxis=srt_MinimumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_RangeAxis=srt_MaximumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

License and Other Agreements - Sosei Heptares (Details) - USD ($) $ in Thousands	1 Months Ended	3 Months Ended
	Nov. 30, 2020	Mar. 31, 2021	Mar. 31, 2020
License and other agreements
Payment for license agreement		$ 0	$ 20,750
Issuance of common shares as payment for assets		10,243
Research and development expense		107,111	$ 56,070
Sosei Heptares \| Collaborative arrangement
License and other agreements
Eligible milestone payment per agreement upon specified performance and regulatory milestones	$ 370,000
Initial term of agreement (in years)	10 years
Notice period to terminate agreement during research term	180 days
Notice period to terminate agreement following research term	90 days
Counterparty notice period after research term to terminate agreement	30 days
Counterparty continuous period for development activities	365 days
Research and development expense		$ 617
Sosei Heptares \| Collaborative arrangement \| Minimum
License and other agreements
Earned royalty payment per agreement (percent)	0.00%
Sosei Heptares \| Collaborative arrangement \| Maximum
License and other agreements
Earned royalty payment per agreement (percent)	10.00%
Sosei Heptares \| Collaborative arrangement \| License agreement
License and other agreements
Payment for license agreement	$ 5,000
Issuance of common shares as payment for assets (in shares)	54,617
Issuance of common shares as payment for assets	$ 4,858